{"disease":{"id":"malaria","name":"Malaria","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":4,"pipeline_drug_count":0,"trial_count":15},"drugs":{"marketed":[{"drug_id":"hydroxychloroquine","indication_name":"Uncomplicated malaria treatment","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"HYDROXYCHLOROQUINE","company_name":"Advanz","drug_phase":"marketed","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":75,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and reducing inflammation in the body."},{"drug_id":"hydroxychloroquine","indication_name":"Malaria prophylaxis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"HYDROXYCHLOROQUINE","company_name":"Advanz","drug_phase":"marketed","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":75,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and reducing inflammation in the body."},{"drug_id":"tafenoquine","indication_name":"Malaria Prophylaxis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Krintafel","generic_name":"TAFENOQUINE","company_name":"60 Degrees Pharms","drug_phase":"marketed","molecular_target":"","drug_class":"tafenoquine","quality_score":55,"revenue":null,"mechanism":"Tafenoquine works by targeting the parasite's heme detoxification pathway, preventing the parasite from producing heme and ultimately leading to its death."},{"drug_id":"atovaquone-and-proguanil","indication_name":"Prophylaxis of P. falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Atovaquone and Proguanil","company_name":"State University of New York - Upstate Medical University","drug_phase":"marketed","molecular_target":"","drug_class":"Antimalarial [EPC]","quality_score":40,"revenue":null,"mechanism":null},{"drug_id":"atovaquone-and-proguanil","indication_name":"Treatment of acute, uncomplicated P. falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Atovaquone and Proguanil","company_name":"State University of New York - Upstate Medical University","drug_phase":"marketed","molecular_target":"","drug_class":"Antimalarial [EPC]","quality_score":40,"revenue":null,"mechanism":null},{"drug_id":"doxycycline","indication_name":"Malaria prophylaxis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vibramycin","generic_name":"doxycycline","company_name":"Generic (originally Pfizer)","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"Tetracycline antibiotic","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"fusidic-acid","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ramycin","generic_name":"FUSIDIC ACID","company_name":"","drug_phase":"phase_3","molecular_target":"Bile salt export pump","drug_class":"fusidic acid","quality_score":47,"revenue":null,"mechanism":"Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins."},{"drug_id":"artesunate","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Artesunate","generic_name":"ARTESUNATE","company_name":"Amivas","drug_phase":"marketed","molecular_target":"","drug_class":"artesunate","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"artesunate","indication_name":"Vivax malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Artesunate","generic_name":"ARTESUNATE","company_name":"Amivas","drug_phase":"marketed","molecular_target":"","drug_class":"artesunate","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"doxycyclin","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Doxycyclin","company_name":"Bulovka Hospital","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"hydroxychloroquine-pill","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"hydroxychloroquine-pill","company_name":"Sanofi","drug_phase":"discontinued","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":null,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and modulating the immune system to treat autoimmune diseases."},{"drug_id":"hydroxychloroquine-pill","indication_name":"Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"hydroxychloroquine-pill","company_name":"Sanofi","drug_phase":"discontinued","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":null,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and modulating the immune system to treat autoimmune diseases."},{"drug_id":"hydroxychloroquine-pill","indication_name":"Ovale malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"hydroxychloroquine-pill","company_name":"Sanofi","drug_phase":"discontinued","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":null,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and modulating the immune system to treat autoimmune diseases."},{"drug_id":"hydroxychloroquine-pill","indication_name":"Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"hydroxychloroquine-pill","company_name":"Sanofi","drug_phase":"discontinued","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":null,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and modulating the immune system to treat autoimmune diseases."},{"drug_id":"hydroxychloroquine-pill","indication_name":"Plasmodium Malariae Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"hydroxychloroquine-pill","company_name":"Sanofi","drug_phase":"discontinued","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":null,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and modulating the immune system to treat autoimmune diseases."},{"drug_id":"hydroxychloroquine-pill","indication_name":"Plasmodium Ovale Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"hydroxychloroquine-pill","company_name":"Sanofi","drug_phase":"discontinued","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":null,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and modulating the immune system to treat autoimmune diseases."},{"drug_id":"hydroxychloroquine-pill","indication_name":"Quartan malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"hydroxychloroquine-pill","company_name":"Sanofi","drug_phase":"discontinued","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":null,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and modulating the immune system to treat autoimmune diseases."},{"drug_id":"hydroxychloroquine-pill","indication_name":"Vivax malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"hydroxychloroquine-pill","company_name":"Sanofi","drug_phase":"discontinued","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":null,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and modulating the immune system to treat autoimmune diseases."},{"drug_id":"sulfafurazole","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Azo Gantrisin","generic_name":"sulfafurazole","company_name":"Alra","drug_phase":"marketed","molecular_target":"Endothelin-1 receptor","drug_class":"Sulfonamide Antimicrobial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"quinidine-sulfate","indication_name":"Malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Quinidine Gluconate","generic_name":"QUINIDINE SULFATE","company_name":"Eli Lilly","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M2","drug_class":"Antiarrhythmic","quality_score":10,"revenue":null,"mechanism":"Quinidine Gluconate works by blocking the M2 muscarinic acetylcholine receptor, which helps regulate heart rhythm."},{"drug_id":"artemisinin","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Artemef","generic_name":"ARTEMISININ","company_name":"","drug_phase":"phase_3","molecular_target":"Cytochrome P450 1A2","drug_class":"artemisinin","quality_score":31,"revenue":null,"mechanism":"Artemef works by generating reactive oxygen species that rapidly kill malaria parasites."},{"drug_id":"lumefantrine","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Coartem","generic_name":"LUMEFANTRINE","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Potassium voltage-gated channel subfamily H member 2","drug_class":"Antimalarial [EPC]","quality_score":65,"revenue":null,"mechanism":"Coartem Tablets, a combination of artemether and lumefantrine, act as an antimalarial agent."},{"drug_id":"halofantrine","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Halfan","generic_name":"HALOFANTRINE","company_name":"GSK","drug_phase":"marketed","molecular_target":"Potassium voltage-gated channel subfamily H member 2","drug_class":"Antimalarial","quality_score":33,"revenue":null,"mechanism":""},{"drug_id":"halofantrine","indication_name":"Vivax malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Halfan","generic_name":"HALOFANTRINE","company_name":"GSK","drug_phase":"marketed","molecular_target":"Potassium voltage-gated channel subfamily H member 2","drug_class":"Antimalarial","quality_score":33,"revenue":null,"mechanism":""},{"drug_id":"arsuamoon","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Arsuamoon","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":7,"revenue":null,"mechanism":null},{"drug_id":"arsuamoon","indication_name":"Vivax malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Arsuamoon","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":7,"revenue":null,"mechanism":null},{"drug_id":"mefloquine","indication_name":"Chloroquine Resistant Plasmodium Falciparum Malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lariam","generic_name":"MEFLOQUINE","company_name":"","drug_phase":"marketed","molecular_target":"Adenosine receptor A2a","drug_class":"Antimalarial","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"mefloquine","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lariam","generic_name":"MEFLOQUINE","company_name":"","drug_phase":"marketed","molecular_target":"Adenosine receptor A2a","drug_class":"Antimalarial","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"mefloquine","indication_name":"Vivax malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lariam","generic_name":"MEFLOQUINE","company_name":"","drug_phase":"marketed","molecular_target":"Adenosine receptor A2a","drug_class":"Antimalarial","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"tafenoquine","indication_name":"Malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Krintafel","generic_name":"TAFENOQUINE","company_name":"60 Degrees Pharms","drug_phase":"marketed","molecular_target":"","drug_class":"tafenoquine","quality_score":55,"revenue":null,"mechanism":"Tafenoquine works by targeting the parasite's heme detoxification pathway, preventing the parasite from producing heme and ultimately leading to its death."},{"drug_id":"artenimol","indication_name":"Malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Alaxin","generic_name":"ARTENIMOL","company_name":"Sigma-Tau Industrie Farmaceutiche Riunite S.p.A","drug_phase":"marketed","molecular_target":"","drug_class":"artenimol","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"chloroquine","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aralen","generic_name":"CHLOROQUINE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Antimalarial","quality_score":65,"revenue":null,"mechanism":"Aralen works by accumulating in the acidic compartments of the malaria parasite, disrupting its metabolism and ultimately leading to its death."},{"drug_id":"chloroquine","indication_name":"Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aralen","generic_name":"CHLOROQUINE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Antimalarial","quality_score":65,"revenue":null,"mechanism":"Aralen works by accumulating in the acidic compartments of the malaria parasite, disrupting its metabolism and ultimately leading to its death."},{"drug_id":"chloroquine","indication_name":"Ovale malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aralen","generic_name":"CHLOROQUINE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Antimalarial","quality_score":65,"revenue":null,"mechanism":"Aralen works by accumulating in the acidic compartments of the malaria parasite, disrupting its metabolism and ultimately leading to its death."},{"drug_id":"chloroquine","indication_name":"Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aralen","generic_name":"CHLOROQUINE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Antimalarial","quality_score":65,"revenue":null,"mechanism":"Aralen works by accumulating in the acidic compartments of the malaria parasite, disrupting its metabolism and ultimately leading to its death."},{"drug_id":"chloroquine","indication_name":"Plasmodium Malariae Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aralen","generic_name":"CHLOROQUINE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Antimalarial","quality_score":65,"revenue":null,"mechanism":"Aralen works by accumulating in the acidic compartments of the malaria parasite, disrupting its metabolism and ultimately leading to its death."},{"drug_id":"chloroquine","indication_name":"Plasmodium Ovale Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aralen","generic_name":"CHLOROQUINE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Antimalarial","quality_score":65,"revenue":null,"mechanism":"Aralen works by accumulating in the acidic compartments of the malaria parasite, disrupting its metabolism and ultimately leading to its death."},{"drug_id":"chloroquine","indication_name":"Quartan malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aralen","generic_name":"CHLOROQUINE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Antimalarial","quality_score":65,"revenue":null,"mechanism":"Aralen works by accumulating in the acidic compartments of the malaria parasite, disrupting its metabolism and ultimately leading to its death."},{"drug_id":"chloroquine","indication_name":"Vivax malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aralen","generic_name":"CHLOROQUINE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Antimalarial","quality_score":65,"revenue":null,"mechanism":"Aralen works by accumulating in the acidic compartments of the malaria parasite, disrupting its metabolism and ultimately leading to its death."},{"drug_id":"quinine","indication_name":"Chloroquine Resistant Plasmodium Falciparum Malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Qualaquin","generic_name":"QUININE","company_name":"Sun Pharm Industries","drug_phase":"marketed","molecular_target":"Sodium channel alpha subunits; brain (Types I, II, III)","drug_class":"Antimalarial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"quinine","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Qualaquin","generic_name":"QUININE","company_name":"Sun Pharm Industries","drug_phase":"marketed","molecular_target":"Sodium channel alpha subunits; brain (Types I, II, III)","drug_class":"Antimalarial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"hydroxychloroquine","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"HYDROXYCHLOROQUINE","company_name":"Advanz","drug_phase":"marketed","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":75,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and reducing inflammation in the body."},{"drug_id":"hydroxychloroquine","indication_name":"Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"HYDROXYCHLOROQUINE","company_name":"Advanz","drug_phase":"marketed","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":75,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and reducing inflammation in the body."},{"drug_id":"hydroxychloroquine","indication_name":"Ovale malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"HYDROXYCHLOROQUINE","company_name":"Advanz","drug_phase":"marketed","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":75,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and reducing inflammation in the body."},{"drug_id":"hydroxychloroquine","indication_name":"Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"HYDROXYCHLOROQUINE","company_name":"Advanz","drug_phase":"marketed","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":75,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and reducing inflammation in the body."},{"drug_id":"hydroxychloroquine","indication_name":"Plasmodium Malariae Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"HYDROXYCHLOROQUINE","company_name":"Advanz","drug_phase":"marketed","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":75,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and reducing inflammation in the body."},{"drug_id":"hydroxychloroquine","indication_name":"Plasmodium Ovale Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"HYDROXYCHLOROQUINE","company_name":"Advanz","drug_phase":"marketed","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":75,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and reducing inflammation in the body."},{"drug_id":"hydroxychloroquine","indication_name":"Quartan malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"HYDROXYCHLOROQUINE","company_name":"Advanz","drug_phase":"marketed","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":75,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and reducing inflammation in the body."},{"drug_id":"hydroxychloroquine","indication_name":"Vivax malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"HYDROXYCHLOROQUINE","company_name":"Advanz","drug_phase":"marketed","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":75,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and reducing inflammation in the body."},{"drug_id":"artesunate-amodiaquine-as-aq","indication_name":"Treatment of acute, uncomplicated Plasmodium falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"artesunate-amodiaquine (AS-AQ)","company_name":"Yale University","drug_phase":"marketed","molecular_target":"Plasmodium falciparum heme iron (Fe2+), parasite DNA, heme polymerase","drug_class":"Artemisinin derivative + aminoquinoline antimalarial combination","quality_score":22,"revenue":null,"mechanism":""},{"drug_id":"proguanil","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Malarone","generic_name":"PROGUANIL","company_name":"GSK","drug_phase":"marketed","molecular_target":"","drug_class":"Antimalarial [EPC]","quality_score":60,"revenue":null,"mechanism":"Malarone works by inhibiting the parasite's ability to synthesize nucleic acids, ultimately preventing its replication and spread within the body."},{"drug_id":"proguanil","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Malarone","generic_name":"PROGUANIL","company_name":"GSK","drug_phase":"marketed","molecular_target":"","drug_class":"Antimalarial [EPC]","quality_score":60,"revenue":null,"mechanism":"Malarone works by inhibiting the parasite's ability to synthesize nucleic acids, ultimately preventing its replication and spread within the body."},{"drug_id":"proguanil","indication_name":"Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Malarone","generic_name":"PROGUANIL","company_name":"GSK","drug_phase":"marketed","molecular_target":"","drug_class":"Antimalarial [EPC]","quality_score":60,"revenue":null,"mechanism":"Malarone works by inhibiting the parasite's ability to synthesize nucleic acids, ultimately preventing its replication and spread within the body."},{"drug_id":"artemether","indication_name":"Chloroquine Resistant Plasmodium Falciparum Malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Coartem","generic_name":"ARTEMETHER","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Antimalarial [EPC]","quality_score":10,"revenue":null,"mechanism":"Artemether works by rapidly killing malaria parasites in the blood and liver."},{"drug_id":"arterolane","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ARTEROLANE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"mefloquine-hydrochloride","indication_name":"Chloroquine Resistant Plasmodium Falciparum Malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lariam","generic_name":"MEFLOQUINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"Adenosine receptor A2a","drug_class":"Antimalarial","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"mefloquine-hydrochloride","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lariam","generic_name":"MEFLOQUINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"Adenosine receptor A2a","drug_class":"Antimalarial","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"mefloquine-hydrochloride","indication_name":"Vivax malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lariam","generic_name":"MEFLOQUINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"Adenosine receptor A2a","drug_class":"Antimalarial","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"atovaquone","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mepron","generic_name":"ATOVAQUONE","company_name":"","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2","drug_class":"Antimalarial [EPC]","quality_score":10,"revenue":null,"mechanism":"Mepron works by inhibiting the electron transport chain in the mitochondria of Plasmodium parasites, ultimately leading to their death."},{"drug_id":"atovaquone","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mepron","generic_name":"ATOVAQUONE","company_name":"","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2","drug_class":"Antimalarial [EPC]","quality_score":10,"revenue":null,"mechanism":"Mepron works by inhibiting the electron transport chain in the mitochondria of Plasmodium parasites, ultimately leading to their death."},{"drug_id":"atovaquone","indication_name":"Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mepron","generic_name":"ATOVAQUONE","company_name":"","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2","drug_class":"Antimalarial [EPC]","quality_score":10,"revenue":null,"mechanism":"Mepron works by inhibiting the electron transport chain in the mitochondria of Plasmodium parasites, ultimately leading to their death."},{"drug_id":"doxycycline","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vibramycin","generic_name":"doxycycline","company_name":"Generic (originally Pfizer)","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"Tetracycline antibiotic","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"dihydroartemisinin","indication_name":"Malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Dihydroartemisinin","company_name":"Shanghai Zhongshan Hospital","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"hydroxychloroquin","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Hydroxychloroquin","company_name":"Children's Hospital of Fudan University","drug_phase":"marketed","molecular_target":"Transmembrane protein 97, Alpha-1D adrenergic receptor, Alpha-2A adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"hydroxychloroquin","indication_name":"Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Hydroxychloroquin","company_name":"Children's Hospital of Fudan University","drug_phase":"marketed","molecular_target":"Transmembrane protein 97, Alpha-1D adrenergic receptor, Alpha-2A adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"hydroxychloroquin","indication_name":"Ovale malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Hydroxychloroquin","company_name":"Children's Hospital of Fudan University","drug_phase":"marketed","molecular_target":"Transmembrane protein 97, Alpha-1D adrenergic receptor, Alpha-2A adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"hydroxychloroquin","indication_name":"Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Hydroxychloroquin","company_name":"Children's Hospital of Fudan University","drug_phase":"marketed","molecular_target":"Transmembrane protein 97, Alpha-1D adrenergic receptor, Alpha-2A adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"hydroxychloroquin","indication_name":"Plasmodium Malariae Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Hydroxychloroquin","company_name":"Children's Hospital of Fudan University","drug_phase":"marketed","molecular_target":"Transmembrane protein 97, Alpha-1D adrenergic receptor, Alpha-2A adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"hydroxychloroquin","indication_name":"Plasmodium Ovale Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Hydroxychloroquin","company_name":"Children's Hospital of Fudan University","drug_phase":"marketed","molecular_target":"Transmembrane protein 97, Alpha-1D adrenergic receptor, Alpha-2A adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"hydroxychloroquin","indication_name":"Quartan malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Hydroxychloroquin","company_name":"Children's Hospital of Fudan University","drug_phase":"marketed","molecular_target":"Transmembrane protein 97, Alpha-1D adrenergic receptor, Alpha-2A adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"hydroxychloroquin","indication_name":"Vivax malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Hydroxychloroquin","company_name":"Children's Hospital of Fudan University","drug_phase":"marketed","molecular_target":"Transmembrane protein 97, Alpha-1D adrenergic receptor, Alpha-2A adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":71,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05950191","title":"LLIN Evaluation in Uganda Project (LLINEUP3)","phase":"NA","overall_status":"COMPLETED","enrollment_count":215903,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT04265573","title":"Feasibility, Acceptability and Costs of a Multiple First-lines Artemisinin-based Combination Therapies","phase":"","overall_status":"COMPLETED","enrollment_count":150000,"lead_sponsor_name":"Groupe de Recherche Action en Sante","has_results":false},{"nct_id":"NCT05085340","title":"MULTIple Doses of IPTi Proposal: a Lifesaving High Yield Intervention","phase":"","overall_status":"COMPLETED","enrollment_count":94252,"lead_sponsor_name":"Barcelona Institute for Global Health","has_results":false},{"nct_id":"NCT03855995","title":"A Study Assessing the Safety, Efficacy, and Impact of GlaxoSmithKline Biologicals' RTS, S/AS01E Malaria Vaccine in Young Children Across Sub-Saharan Africa","phase":"","overall_status":"COMPLETED","enrollment_count":77953,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT07436104","title":"Mortality Control Program for Economically Productive Age Group in Tribal Area of Melghat.","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":72564,"lead_sponsor_name":"MAHAN Trust","has_results":false},{"nct_id":"NCT02251704","title":"Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":54115,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT05052502","title":"Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand","phase":"NA","overall_status":"UNKNOWN","enrollment_count":49118,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT04241705","title":"Evaluation of Targeted Mass Drug Administration for Malaria in Ethiopia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":48960,"lead_sponsor_name":"Armauer Hansen Research Institute, Ethiopia","has_results":false},{"nct_id":"NCT04966702","title":"Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":48145,"lead_sponsor_name":"Barcelona Institute for Global Health","has_results":false},{"nct_id":"NCT03783299","title":"Targeted Active Case Detection Among High Risk Populations in Southern Lao Peoples Democratic Republic","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":39968,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT02374450","title":"A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine","phase":"","overall_status":"COMPLETED","enrollment_count":36366,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT06870344","title":"IGHID 12334 - After the Flood: Optimal Strategies to Prevent Malaria Epidemics Caused by Severe Flooding","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":36000,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT04566510","title":"LLIN Evaluation in Uganda Project","phase":"NA","overall_status":"COMPLETED","enrollment_count":32895,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT04416945","title":"Targeting High Risk Populations With Enhanced Reactive Case Detection in Southern Lao Peoples Democratic Republic","phase":"NA","overall_status":"UNKNOWN","enrollment_count":31443,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT03806465","title":"Malaria Vaccine Pilot Evaluation","phase":"","overall_status":"COMPLETED","enrollment_count":30124,"lead_sponsor_name":"Rafiq OKINE","has_results":false},{"nct_id":"NCT06560853","title":"Evaluation of a Comprehensive School Health Programme in Zambia","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":28700,"lead_sponsor_name":"London School of Economics and Political Science","has_results":false},{"nct_id":"NCT05123378","title":"Liberia National Community Health Assistant (NCHA) Program and Under-five Mortality","phase":"NA","overall_status":"UNKNOWN","enrollment_count":23702,"lead_sponsor_name":"Last Mile Health","has_results":false},{"nct_id":"NCT07387341","title":"Long-acting Spatial Emanators / Repellents (LASER)","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":22815,"lead_sponsor_name":"Liverpool School of Tropical Medicine","has_results":false},{"nct_id":"NCT02721186","title":"Effectiveness of Mass Drug Administration for Reducing Seasonal Malaria Transmission in Zanzibar","phase":"NA","overall_status":"COMPLETED","enrollment_count":22500,"lead_sponsor_name":"Ulrika Morris","has_results":false},{"nct_id":"NCT05306067","title":"Plasmodium Falciparum Genomic Intelligence in Mozambique","phase":"","overall_status":"COMPLETED","enrollment_count":21848,"lead_sponsor_name":"Centro de Investigacao em Saude de Manhica","has_results":false},{"nct_id":"NCT01190202","title":"Epidemiology Study of Malaria Transmission Intensity in Africa","phase":"NA","overall_status":"COMPLETED","enrollment_count":21618,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT04724161","title":"Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Mozambique","phase":"","overall_status":"COMPLETED","enrollment_count":19215,"lead_sponsor_name":"PATH","has_results":false},{"nct_id":"NCT06923592","title":"Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":19200,"lead_sponsor_name":"London School of Hygiene and Tropical Medicine","has_results":false},{"nct_id":"NCT06529237","title":"Malaria Molecular Surveillance in Mozambique (Phase 2)","phase":"","overall_status":"RECRUITING","enrollment_count":18750,"lead_sponsor_name":"Centro de Investigacao em Saude de Manhica","has_results":false},{"nct_id":"NCT06578572","title":"Seasonal R21 Mass Vaccination for Malaria Elimination","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":16200,"lead_sponsor_name":"London School of Hygiene and Tropical Medicine","has_results":false},{"nct_id":"NCT05096702","title":"Operational Feasibility of Appropriate Radical Cure of Plasmodium Vivax With Tafenoquine or Primaquine After Quantitative G6PD Testing in Brazil","phase":"","overall_status":"UNKNOWN","enrollment_count":16000,"lead_sponsor_name":"Fundação de Medicina Tropical Dr. Heitor Vieira Dourado","has_results":false},{"nct_id":"NCT00866619","title":"Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in Africa","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":15459,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01168271","title":"Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT05874869","title":"Dihydroartemisinin-piperaquine for Seasonal Malaria Chemoprophylaxis in Tanzania","phase":"NA","overall_status":"COMPLETED","enrollment_count":13800,"lead_sponsor_name":"Richard Mwaiswelo","has_results":false},{"nct_id":"NCT03568344","title":"Community Access to Rectal Artesunate for Malaria","phase":"","overall_status":"COMPLETED","enrollment_count":13758,"lead_sponsor_name":"Swiss Tropical & Public Health Institute","has_results":false},{"nct_id":"NCT04545905","title":"Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina Faso","phase":"","overall_status":"COMPLETED","enrollment_count":13350,"lead_sponsor_name":"PATH","has_results":false},{"nct_id":"NCT05946642","title":"Innovative Intermittent Preventive Treatment Approaches to Reduce Malaria Burden in School-age Children in Burkina Faso","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":13000,"lead_sponsor_name":"Malaria Consortium","has_results":false},{"nct_id":"NCT05150808","title":"Vectron T500 (Broflanilide 50WP) for IRS in Tanzania Tanzania","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":12500,"lead_sponsor_name":"London School of Hygiene and Tropical Medicine","has_results":false},{"nct_id":"NCT04839900","title":"Proactive Community Case Management for Malaria in Zambia","phase":"NA","overall_status":"COMPLETED","enrollment_count":10890,"lead_sponsor_name":"PATH","has_results":false},{"nct_id":"NCT04864444","title":"Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination Activities","phase":"NA","overall_status":"COMPLETED","enrollment_count":10715,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT03600844","title":"Evaluating the Effects of Community Delivery of Malaria Intermittent Preventive Treatment on Pregnant Women and Babies","phase":"NA","overall_status":"COMPLETED","enrollment_count":10602,"lead_sponsor_name":"Jhpiego","has_results":false},{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT04672577","title":"Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Patricia Schlagenhauf","has_results":false},{"nct_id":"NCT06068530","title":"Mass Vaccine and Drug Administration, Bangladesh","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT05041556","title":"Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria Vaccine","phase":"","overall_status":"RECRUITING","enrollment_count":9280,"lead_sponsor_name":"Kintampo Health Research Centre, Ghana","has_results":false},{"nct_id":"NCT07389057","title":"Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of Ghana","phase":"NA","overall_status":"RECRUITING","enrollment_count":9000,"lead_sponsor_name":"Noguchi Memorial Institute for Medical Research","has_results":false},{"nct_id":"NCT04716387","title":"Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in Mozambique","phase":"","overall_status":"COMPLETED","enrollment_count":8726,"lead_sponsor_name":"PATH","has_results":false},{"nct_id":"NCT03201770","title":"Cohort Event Monitoring Study of Pyramax®","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":8572,"lead_sponsor_name":"Shin Poong Pharmaceutical Co. Ltd.","has_results":false},{"nct_id":"NCT02974608","title":"Impact of Malaria on Pregnant Women in Ouelessebougou, Mali","phase":"","overall_status":"COMPLETED","enrollment_count":7691,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT05690841","title":"FocaL Mass Drug Administration for Vivax Malaria Elimination","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":7530,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT05535465","title":"Malaria Control : Improving Access to Prevention, Diagnostic and Care for Vulnerable Rural Communities","phase":"NA","overall_status":"UNKNOWN","enrollment_count":7500,"lead_sponsor_name":"Institut de Recherche pour le Developpement","has_results":false},{"nct_id":"NCT02471378","title":"Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates","phase":"","overall_status":"RECRUITING","enrollment_count":7476,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03998839","title":"TIPTOP Sulfadoxine-pyrimethamine (SP) Drug Resistance Study","phase":"","overall_status":"COMPLETED","enrollment_count":7200,"lead_sponsor_name":"Jhpiego","has_results":false},{"nct_id":"NCT05072613","title":"Monitoring Pregnant Women for Antimalarial Drug Resistance","phase":"","overall_status":"COMPLETED","enrollment_count":6833,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT05323721","title":"Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Karamoja Region, Uganda","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":6805,"lead_sponsor_name":"Malaria Consortium","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}